Ownership of Existing Intellectual Property. Except as set forth below in Section 11.3 and except as such rights are expressly licensed by one Party to the other Party hereunder, Liquidia shall retain all of its rights, title and interest in and to the Liquidia Technology existing prior to the Effective Date or arising outside of this Agreement and the Vaccine Collaboration Agreement, and GSK shall retain all of its rights, title and interest in and to the GSK Technology existing prior to the Effective Date or arising outside of this Agreement and the Vaccine Collaboration Agreement, and in the case of PRINT Improvements, arising under this Agreement after the Inhaled Collaboration Term.
Ownership of Existing Intellectual Property. Ownership of and intellectual property rights in and to Monsanto Enabling Technology and Glyphosate Tolerance Genes, and biological material related to any of the foregoing remain unchanged by this Agreement.
Ownership of Existing Intellectual Property. Subject to the license and other rights granted to RO in Section 2.2, as between the Parties, GELESIS shall own all right, title, and interest in and to the Product Trademarks, the Company Names, and the other intellectual property owned or controlled by GELESIS prior to the Effective Date and developed or acquired by GELESIS during the Term independently of this Agreement (collectively, “GELESIS Intellectual Property”), and RO shall own all right, title, and interest in and to all intellectual property owned or controlled by RO prior to the Effective Date and developed or acquired by RO during the Term independently of this Agreement (collectively, “RO Intellectual Property”). All license rights to GELESIS Intellectual Property not specifically granted under this Agreement are expressly reserved by GELESIS. Any license granted in this Agreement may be transferred or assigned only in connection with a permitted assignment of this Agreement under Section 14.4.
Ownership of Existing Intellectual Property. Each party shall retain sole and exclusive ownership of all Intellectual Property owned or controlled by such party prior to this Agreement or developed by or for such party outside of the course of performance of this Agreement. Except as specifically set forth in this Agreement, this Agreement shall not be construed as granting the other party, by implication or otherwise, any rights or license with respect to such Intellectual Property.
Ownership of Existing Intellectual Property. Except as expressly stated in this Agreement the ownership of the Intellectual Property Rights of each of the Parties as at the date of commencement of this Agreement and/or an applicable Statement of Work shall remain vested in that Party. Where there are modifications or enhancements to pre-existing material which are inseparable from the pre-existing material, then the Party which owns the pre-existing material will own the modifications or enhancements to such pre-existing material.
Ownership of Existing Intellectual Property. Alliance Members will retain all right, title, and interest in all Intellectual Property they individually owned prior to this Agreement.
Ownership of Existing Intellectual Property. Rights All Intellectual Property Rights that were either developed or otherwise acquired by a Party before entering into this Manufacturing Agreement, or are developed or otherwise acquired by a Party outside of, but during the term of, this Manufacturing Agreement, will continue to be owned by such Party. 17.6.4 [***] 18. INSPECTION RIGHTS 18.1 During the term of the Manufacturing Agreement, Buyer shall have the right to, at its own cost and expenses, at the maximum [***]unless the Buyer is required by governmental authority to conduct an inspection on the Supplier provided that the Buyer shall prove such a need to conduct an inspection by providing the Supplier with written documents issued by such governmental authority, upon prior written notice allowing sufficient time for Supplier to accommodate such request which in normal cases shall be at least [***]in advance of the proposed inspection date, to the Supplier with necessary details of such request, inspect Supplier’s books and records related to the Vehicles delivered under this Manufacturing Agreement, in order to conduct quality controls and otherwise verify the statements rendered under this Manufacturing Agreement. The parties will agree on a case by case basis and in good faith on which kind of books and records and to which extent such information will be provided. If the review of information in books and records provided by Supplier is not sufficient, then Buyer shall be granted the reasonable right to,
18.2 Such inspection shall not interfere normal operations of the Supplier, especially the manufacturing Plant, and be made during regular business hours.
18.3 In case that the Buyer is not capable to perform inspection by itself due to lack of competence, resources or under Force Majeure circumstances, the Buyer can appoint in writing an independent third party (provided that the Buyer shall always ensure that such third party will comply with Section 25). The Buyer shall inform the Supplier on the proposed independent third party and if there could be any conflict of interest, both Parties shall discuss in good faith and reach a practical solution within fifteen (15) business days from the commencement of the discussion, failing which the Parties shall escalate such issue according to the escalation principles under Section 27.
Ownership of Existing Intellectual Property. Rights 3.
Ownership of Existing Intellectual Property. (a) RGI shall retain all of its rights, title and interest in and to the RGI Patents and RGI Technology that RGI Controls as of the Effective Date. Except as provided in this Agreement, GSK shall not have any claims to or rights in the RGI Patents and RGI Technology Controlled by RGI as of the Effective Date.
(b) GSK shall retain all of its rights, title and interest in and to any patents and know-how Controlled by GSK as of the Effective Date. RGI shall not have any claims to any patents or know-how Controlled by GSK as of the Effective Date.
Ownership of Existing Intellectual Property. Subject to the terms of this Agreement, including the licenses granted in Section 5.1, as between the Parties, each Party shall retain ownership of any Regulatory Documentation (other than, in the case of EOS, the Regulatory Documentation transferred and assigned to Licensee pursuant to Section 2.2.1), Information, Patents and Intellectual Property Rights owned or Controlled by such Party, its Affiliates, its licensees or its sublicensees prior to execution of this Agreement, including in the case of EOS as the retaining Party, all right, title and interest in and to all EOS Technology and the Licensed Trademarks, and in the case of Licensee, all right, title and interest in and to the Licensee Technology.
